Nilsine Partners’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2.76M	Buy	127,139 +71,890	+130%	+$1.56M	0.28%	93
2025 Q1	$1.34M	Buy	55,249 +21,730	+65%	+$527K	0.15%	146
2024 Q4	$700K	Buy	+33,519	New	+$700K	0.07%	215